Workflow
Is the Options Market Predicting a Spike in CGI Group Stock?
ZACKS· 2025-09-02 23:00
期权市场动态 - 2025年11月21日到期、行权价75美元的看跌期权隐含波动率创当日所有股票期权最高水平 [1] - 高隐含波动率表明市场预期股价将出现大幅单向波动 或预示即将发生可能引发大涨或暴跌的事件 [2] 分析师观点与业绩预期 - 公司获Zacks计算机服务行业排名前40% 当前Zacks评级为4级(卖出)[3] - 过去60天内3名分析师上调当季盈利预期 1名分析师下调预期 [3] - Zacks共识预期从每股1.52美元升至1.53美元 [3] 交易策略动向 - 期权交易员可能利用高隐含波动率出售权利金 通过时间价值衰减获利 [4] - 成熟交易员期望标的股票波动幅度低于市场预期以实现策略收益 [4]
Can Korlym Drive Corcept's Growth Through the Rest of 2025?
ZACKS· 2025-09-02 23:00
核心产品Korlym销售表现 - Korlym是公司唯一上市药物 用于治疗库欣综合征或内源性高皮质醇血症 公司收入完全依赖该产品[1] - 2025年上半年Korlym销售额达3.516亿美元 同比增长13.2%[1][9] - 预计2025年全年Korlym销售额将达8.571亿美元 同比增长近27%[1] - 第一季度因专业药房供应商产能不足影响销售 第二季度情况改善[2] - 管理层预期下半年处方量将显著增长 全年总收入指引8.5-9亿美元[2][3] 研发管线进展 - 主要候选药物relacorilant针对库欣综合征的新药申请已于2024年12月提交FDA[4] - FDA设定处方药用户费用法案目标行动日期为2025年12月30日[4] - 获批后现有Korlym患者将全部转换至relacorilant 有望加速增长并降低对单一产品依赖[5] - 同时开发relacorilant联合疗法:与nab-紫杉醇联用治疗铂耐药卵巢癌的NDA已提交[6] - 开展II期BELLA研究 评估relacorilant联合nab-紫杉醇和罗氏Avastin治疗铂耐药卵巢癌[6][7] - 另有一项研究评估relacorilant联合默克Keytruda治疗肾上腺癌伴皮质醇过量[7] 股价表现与估值 - 年初至今股价上涨38.3% 远超行业8.3%的涨幅[8] - 按市销率计算 公司当前交易倍数11.73倍 显著高于行业2.38倍和自身五年均值7.52倍[10] - 过去60天内2025年每股收益共识预期从1.39美元下调至1.15美元 2026年从2.08美元下调至1.71美元[11]
Best Momentum Stock to Buy for September 2nd
ZACKS· 2025-09-02 23:00
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, September 2nd:Sportradar Group (SRAD) :This company which is a provider of sports betting and sports entertainment products and services, has a Zacks Rank #1 (Strong Buy), and witnessed the Zacks Consensus Estimate for its current year earnings increasing 41.9% over the last 60 days.Sportradar Group's shares gained 28.9% over the last three month compared with the S&P 500’s gain of 8.8%. The company poss ...
Dave & Buster's (PLAY) Expected to Beat Earnings Estimates: Should You Buy?
ZACKS· 2025-09-02 23:00
The market expects Dave & Buster's (PLAY) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended July 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report. On the other hand, if they miss ...
Onfolio Holdings' Subsidiary Eastern Standard Launches Precision Metrics Custom Dashboards to Help Organizations Decode Website Analytics Data and Drive Results
Globenewswire· 2025-09-02 23:00
WILMINGTON, Del., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Onfolio Holdings Inc. (NASDAQ: ONFO, ONFOW) (OTC: ONFOP) ("Onfolio" or the "Company") today announced that its digital and branding agency subsidiary, Eastern Standard LLC, has launched Precision Metrics, a new custom website analytics dashboard solution designed to help clients cut through generic analytics noise to gain actionable insights tied to their unique key performance indicators. Eastern Standard Chief Digital & Technology Director Jim Keller sa ...
Basanite Industries, Inc. Provides Corporate Update
Prnewswire· 2025-09-02 23:00
BRANFORD, Conn., Sept. 2, 2025 /PRNewswire/ -- Basanite Industries, Inc. (OCTQB: BASA) today announced a corporate update to notify shareholders of recent events, the current status of its business affairs, as well as the Company's future intentions.Between August 13th and August 15th of 2025, directors Andrew Acquarulo, Jr., Paul Sallarulo, Sergio Salani, and Fred Tingberg resigned from the Company's Board of Directors. In addition, Jacqueline Placeres and Fred Tingberg resigned from their positions of Chi ...
Chili's Kicks off Colorful Return of Create-A-Pepper Program with All Proceeds Benefiting St. Jude Children's Research Hospital®
Prnewswire· 2025-09-02 23:00
公司慈善活动 - 公司于2025年9月2日宣布重启年度Create-A-Pepper慈善项目 支持圣裘德儿童研究医院的生命拯救工作[1] - 该项目持续时间为2025年9月1日至9月30日 顾客可通过购买1美元、5美元、10美元或25美元的涂色纸参与捐赠[2][3] - 全部捐赠收入将直接用于支持圣裘德医院的治疗研究及患者家庭援助计划 涵盖治疗、交通、住宿和食品费用[2][3] 合作历史与成果 - 公司与圣裘德医院合作已持续23年 自2002年起累计捐赠金额超过1.2亿美元[3][4][6] - 该项目起源于孟菲斯地区餐厅员工发起的社区回馈活动 孟菲斯同时是圣裘德医院的所在地[4] - 合作期间圣裘德医院儿童癌症存活率从20%提升至超过80%[7] 活动执行细节 - 顾客创作的涂色作品将展示在餐厅墙面 用于激励更多参与者[3] - 艺术创作被用作治疗辅助手段 将不确定性时刻转化为美与力量的表达[4] - 活动通过线下餐厅渠道实施 全球29个国家1600家门店同步开展[6] 公司背景信息 - 公司为Brinker International集团旗下旗舰品牌 在休闲餐饮行业处于领导地位[6] - 全球拥有1600家餐厅 覆盖29个国家和两个地区 员工总数超过7万人[6] - 2025年获得Ad Age年度品牌奖及MenuMasters最佳新菜单项奖[6] 圣裘德医院背景 - 该医院是美国国家癌症研究所指定的唯一专门针对儿童的综合性癌症中心[7] - 成立于1962年 专注于儿童癌症及其他危及生命疾病的研究治疗[7] - 研究成果向全球医院共享 用于提升各地儿童癌症治疗质量[7]
HomeTrust Bank Named 2025 Best Place to Work for Women and Best Place to Work in South Carolina
Globenewswire· 2025-09-02 23:00
ASHEVILLE, N.C., Sept. 02, 2025 (GLOBE NEWSWIRE) -- HomeTrust Bancshares, Inc. (NYSE: HTB) (“Company”), the holding company of HomeTrust Bank (“HomeTrust” or the “Bank”), announced today that the Bank has been named a 2025 Best Place to Work for Women and a Best Place to Work in South Carolina by Best Companies Group. 2025 is the inaugural year for the Best Places to Work for Women Award that recognizes the top companies that demonstrate leadership in equity, opportunity, and retention as well as creating e ...
Correction: RCI Banque: ‘’Pillar III Report as at June 30th 2025’’
Globenewswire· 2025-09-02 23:00
September 2nd, 2025 RCI Banque: ‘’Pillar III Report as at June 30th 2025’’ The RCI BANQUE: Pillar Report as at June 30th 2025 is now available on the Mobilize Financial Services website www.mobilize-fs.com. Attachments Press Release - Pillar Risk H12025 PILLAR III risk report as of June 30, 2025 Comex-VF ...
Why Is United Therapeutics Stock Rallying On Tuesday?
Benzinga· 2025-09-02 22:59
United Therapeutics Corporation UTHR released data on Tuesday from its TETON-2 study evaluating the use of nebulized Tyvaso (treprostinil) Inhalation Solution for idiopathic pulmonary fibrosis (IPF).The study met its primary efficacy endpoint of demonstrating improvement in absolute forced vital capacity (FVC) relative to placebo. FVC is a standard pulmonary function test.Tyvaso demonstrated superiority over placebo for the change in absolute FVC by 95.6 mL from baseline to week 52 in patients with IPF.Bene ...